Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation.
D000818:Animals; D001161:Arteriosclerosis; D001241:Aspirin / Q000627:therapeutic use*; D002395:Catecholamines / Q000378:metabolism; D004176:Dipyridamole / Q000627:therapeutic use*; D004285:Dogs; D004837:Epinephrine; D006321:Heart / Q000187:drug effects*; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control; D009206:Myocardium / Q000473:pathology; D009336:Necrosis / Q000139:chemically induced; D010973:Platelet Adhesiveness / Q000187:drug effects*; D013312:Stress, Physiological
D002395:Catecholamines; D004176:Dipyridamole; D001241:Aspirin; D004837:Epinephrine